Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil A Kumar

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hematology/Oncology Clinics of North America|June 27, 2020
The Biological Basis of Histologic TransformationEmil A Kumar, Jessica Okosun, Jude Fitzgibbon
Current Opinion in Hematology|May 9, 2018
Precision medicine and lymphomaJames A Heward, Emil A Kumar, Koorosh Korfi, et al.
Frontiers in Oncology|March 16, 2026
Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson's disease-unfolding clinical challengesAnas Ibraheem, Helena Vincentelli, Andrea Kuhnl, et al.
AIDS (London, England)|September 16, 2015
Renal tubular disease in the era of combination antiretroviral therapyLisa Hamzah, John W Booth, Sophie Jose, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 21, 2016
Clinical characteristics and outcomes of HIV-associated immune complex kidney diseaseJohn W Booth, Lisa Hamzah, Sophie Jose, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Blood Advances|March 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphomaAndrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|June 27, 2020
The Biological Basis of Histologic TransformationEmil A Kumar, Jessica Okosun, Jude Fitzgibbon
Current Opinion in Hematology|May 9, 2018
Precision medicine and lymphomaJames A Heward, Emil A Kumar, Koorosh Korfi, et al.
Frontiers in Oncology|March 16, 2026
Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson's disease-unfolding clinical challengesAnas Ibraheem, Helena Vincentelli, Andrea Kuhnl, et al.
AIDS (London, England)|September 16, 2015
Renal tubular disease in the era of combination antiretroviral therapyLisa Hamzah, John W Booth, Sophie Jose, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 21, 2016
Clinical characteristics and outcomes of HIV-associated immune complex kidney diseaseJohn W Booth, Lisa Hamzah, Sophie Jose, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Blood Advances|March 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphomaAndrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Pageof 1